SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : UTHR-a Promising Biotech in the works here?
UTHR 514.64+0.8%9:30 AM EST

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
From: nicewatch11/9/2004 8:13:56 PM
  Read Replies (1) of 66
 
It's nice to see this board so empty! The recently reported eps was pretty good and there is a chance the stock sees 40 BEFORE the Remodulin IV FDA notice date of November 30.

If they receive approval with a label the stock will tank but I plan on buying that dip because this will still be an increasingly profitable biotech. Looking at the chart since the positive earnings surprise of 8/03/04 it is clear to me that institutions are accumulating and will hump this story through the Remodulin approval. 50 or higher is my target.

Best wishes
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext